-
1
-
-
33947313218
-
HDACs, histone deacetylation and gene transcription: From molecular biology to cancer therapeutics
-
DOI 10.1038/sj.cr.7310149, PII 7310149
-
Gallinari P., Di Marco S., Jones P., Pallaoro M., Steinkühler C.. HDACs, Histone Deacetylation and Gene Transcription: From Molecular Biology to Cancer Therapeutics. Cell Res. 2007 ; 17: 195-211 (Pubitemid 46438722)
-
(2007)
Cell Research
, vol.17
, Issue.3
, pp. 195-211
-
-
Gallinari, P.1
Di Marco, S.2
Jones, P.3
Pallaoro, M.4
Steinkuhler, C.5
-
2
-
-
79952932076
-
Histone Deacetylase Inhibitors: Molecular Mechanisms of Action and Clinical Trials as Anti-cancer Drugs
-
Kim H. J., Bae S. C.. Histone Deacetylase Inhibitors: Molecular Mechanisms of Action and Clinical Trials as Anti-cancer Drugs. Am. J. Transl. Res. 2011 ; 3: 166-179
-
(2011)
Am. J. Transl. Res
, vol.3
, pp. 166-179
-
-
Kim, H.J.1
Bae, S.C.2
-
3
-
-
40049086405
-
The Role of Histone Deacetylases in Asthma and Allergic Diseases
-
Bhavsar P., Ahmad T., Adcock I. M.. The Role of Histone Deacetylases in Asthma and Allergic Diseases. J. Allergy Clin. Immunol. 2008 ; 121: 580-584
-
(2008)
J. Allergy Clin. Immunol
, vol.121
, pp. 580-584
-
-
Bhavsar, P.1
Ahmad, T.2
Adcock, I.M.3
-
4
-
-
84871163185
-
HDAC Inhibitors-New Generation of Target Specific Treatment
-
Chavan A. V., Somani R. R.. HDAC Inhibitors-New Generation of Target Specific Treatment. Mini. Rev. Med. Chem. 2010 ; 10: 1263-1276
-
(2010)
Mini. Rev. Med. Chem
, vol.10
, pp. 1263-1276
-
-
Chavan, A.V.1
Somani, R.R.2
-
5
-
-
71449109387
-
New Patented Histone Deacetylase Inhibitors
-
Wang H., Dymock B. W.. New Patented Histone Deacetylase Inhibitors. Expert Opin. Ther. Pat. 2009 ; 19: 1727-1757
-
(2009)
Expert Opin. Ther. Pat
, vol.19
, pp. 1727-1757
-
-
Wang, H.1
Dymock, B.W.2
-
6
-
-
0037444803
-
Histone deacetylases (HDACs): Characterization of the classical HDAC family
-
DOI 10.1042/BJ20021321
-
de Ruijter A. J., van Gennip A. H., Caron H. N., Kemp S., van Kuilenburg A. B.. Histone Deacetylases (HDACs): Characterization of the Classical HDAC Family. Biochem. J. 2003 ; 15: 737-749 (Pubitemid 36399066)
-
(2003)
Biochemical Journal
, vol.370
, Issue.3
, pp. 737-749
-
-
De Ruijter, A.J.M.1
Van Gennip, A.H.2
Caron, H.N.3
Kemp, S.4
Van Kuilenburg, A.B.P.5
-
7
-
-
65449166411
-
Novel Structural Insights into Class i and II Histone Deacetylases
-
Ficner R.. Novel Structural Insights into Class I and II Histone Deacetylases. Curr. Top. Med. Chem. 2009 ; 9: 235-240
-
(2009)
Curr. Top. Med. Chem
, vol.9
, pp. 235-240
-
-
Ficner, R.1
-
8
-
-
77949887506
-
Mammalian Sirtuins: Biological Insights and Disease Relevance
-
Haigis M. C., Sinclair D. A.. Mammalian Sirtuins: Biological Insights and Disease Relevance. Annu. Rev. Pathol. 2010 ; 5: 253-295
-
(2010)
Annu. Rev. Pathol
, vol.5
, pp. 253-295
-
-
Haigis, M.C.1
Sinclair, D.A.2
-
9
-
-
34447509697
-
Vorinostat: A new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma
-
DOI 10.1517/13543784.16.7.1111
-
Duvic M., Vu J.. Vorinostat: A New Oral Histone Deacetylase Inhibitor Approved for Cutaneous T-Cell Lymphoma. Expert Opin. Investig. Drugs. 2007 ; 16: 1111-1120 (Pubitemid 47074165)
-
(2007)
Expert Opinion on Investigational Drugs
, vol.16
, Issue.7
, pp. 1111-1120
-
-
Duvic, M.1
Vu, J.2
-
10
-
-
78650848615
-
Histone Deacetylase Inhibitors in the Treatment of Lymphoma
-
Lemoine M., Younes A.. Histone Deacetylase Inhibitors in the Treatment of Lymphoma. Discov. Med. 2010 ; 10: 462-470
-
(2010)
Discov. Med
, vol.10
, pp. 462-470
-
-
Lemoine, M.1
Younes, A.2
-
11
-
-
77958523925
-
NAD+-Dependent Histone Deacetylases (Sirtuins) as Novel Therapeutic Targets
-
Schemies J., Uciechowska U., Sippl W., Jung M.. NAD+-Dependent Histone Deacetylases (Sirtuins) as Novel Therapeutic Targets. Med. Res. Rev. 2010 ; 30: 861-889
-
(2010)
Med. Res. Rev
, vol.30
, pp. 861-889
-
-
Schemies, J.1
Uciechowska, U.2
Sippl, W.3
Jung, M.4
-
12
-
-
77957565881
-
Sirtuin-Targeting Drugs: Mechanisms of Action and Potential Therapeutic Applications
-
Aljada A., Dong L., Mousa S. A.. Sirtuin-Targeting Drugs: Mechanisms of Action and Potential Therapeutic Applications. Curr. Opin. Investig. Drugs. 2010 ; 11: 1158-1168
-
(2010)
Curr. Opin. Investig. Drugs
, vol.11
, pp. 1158-1168
-
-
Aljada, A.1
Dong, L.2
Mousa, S.A.3
-
13
-
-
62149085241
-
Pharmaceutical Strategies for Activating Sirtuins
-
Sauve A. A.. Pharmaceutical Strategies for Activating Sirtuins. Curr. Pharm. Des. 2009 ; 15: 45-56
-
(2009)
Curr. Pharm. des
, vol.15
, pp. 45-56
-
-
Sauve, A.A.1
-
14
-
-
0031719840
-
Biochemical Methods for Analysis of Histone Deacetylases
-
Kölle D., Brosch G., Lechner T., Lusser A., Loidl P.. Biochemical Methods for Analysis of Histone Deacetylases. Methods. 1998 ; 15: 323-331
-
(1998)
Methods
, vol.15
, pp. 323-331
-
-
Kölle, D.1
Brosch, G.2
Lechner, T.3
Lusser, A.4
Loidl, P.5
-
15
-
-
46249130572
-
Identification of novel small-molecule histone deacetylase inhibitors by medium-throughput screening using a fluorigenic assay
-
DOI 10.1042/BJ20080536
-
Wegener D., Hildmann C., Riester D., Schober A., Meyer-Almes F. J., Deubzer H. E., Oehme I., Witt O., Lang S., Jaensch M., Makarov V., Lange C., Busse B., Schwienhorst A.. Identification of Novel Small-Molecule Histone Deacetylase Inhibitors by Medium-Throughput Screening Using a Fluorigenic Assay. Biochem. J. 2008 ; 413: 143-150 (Pubitemid 351946870)
-
(2008)
Biochemical Journal
, vol.413
, Issue.1
, pp. 143-150
-
-
Wegener, D.1
Hildmann, C.2
Riester, D.3
Schober, A.4
Meyer-Almes, F.-J.5
Deubzer, H.E.6
Oehme, I.7
Witt, O.8
Lang, S.9
Jaensch, M.10
Makarov, V.11
Lange, C.12
Busse, B.13
Schwienhorst, A.14
-
16
-
-
0347511689
-
Fluorescence readouts in HTS: No gain without pain?
-
DOI 10.1016/S1359-6446(03)02895-2, PII S1359644603028952
-
Gribbon P., Sewing A.. Fluorescence Readouts in HTS: No Gain without Pain?. Drug Discov. Today. 2003 ; 8: 1035-1043 (Pubitemid 38018810)
-
(2003)
Drug Discovery Today
, vol.8
, Issue.22
, pp. 1035-1043
-
-
Gribbon, P.1
Sewing, A.2
-
17
-
-
77953702461
-
Exemplification of the Challenges Associated with Utilising Fluorescence Intensity Based Assays in Discovery
-
Gul S., Gribbon P.. Exemplification of the Challenges Associated with Utilising Fluorescence Intensity Based Assays in Discovery. Expert Opin. Drug Discov. 2010 ; 5: 681-690
-
(2010)
Expert Opin. Drug Discov
, vol.5
, pp. 681-690
-
-
Gul, S.1
Gribbon, P.2
-
18
-
-
17044402932
-
Homogeneous, Bioluminescent Protease Assays: Caspase-3 as a Model
-
O'Brien M. A., Daily W. J., Hesselberth P. E., Moravec R. A., Scurria M. A., Klaubert D. H., Bulleit R. F., Wood K. V.. Homogeneous, Bioluminescent Protease Assays: Caspase-3 as a Model. J. Biomol. Screen. 2005 ; 10: 137-148
-
(2005)
J. Biomol. Screen
, vol.10
, pp. 137-148
-
-
O'Brien, M.A.1
Daily, W.J.2
Hesselberth, P.E.3
Moravec, R.A.4
Scurria, M.A.5
Klaubert, D.H.6
Bulleit, R.F.7
Wood, K.V.8
-
19
-
-
0033003760
-
A simple statistical parameter for use in evaluation and validation of high throughput screening assays
-
DOI 10.1177/108705719900400206
-
Zhang J. H., Chung T. D., Oldenburg K. R.. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J. Biomol. Screen. 1999 ; 4: 67-73 (Pubitemid 29278954)
-
(1999)
Journal of Biomolecular Screening
, vol.4
, Issue.2
, pp. 67-73
-
-
Zhang, J.-H.1
Chung, T.D.Y.2
Oldenburg, K.R.3
-
21
-
-
0037253808
-
A fluorogenic histone deacetylase assay well suited for high-throughput activity screening
-
DOI 10.1016/S1074-5521(02)00305-8
-
Wegener D., Wirsching F., Riester D., Schwienhorst A.. A Fluorogenic Histone Deacetylase Assay Well Suited for High-Throughput Activity Screening. Chem. Biol. 2003 ; 10: 61-68 (Pubitemid 36154475)
-
(2003)
Chemistry and Biology
, vol.10
, Issue.1
, pp. 61-68
-
-
Wegener, D.1
Wirsching, F.2
Riester, D.3
Schwienhorst, A.4
-
22
-
-
74849118854
-
Quantitative Analyses of Aggregation, Autofluorescence, and Reactivity Artifacts in a Screen for Inhibitors of a Thiol Protease
-
Jadhav A., Ferreira R. S., Klumpp C., Mott B. T., Austin C. P., Inglese J., Thomas C. J., Maloney D. J., Shoichet B. K., Simeonov A.. Quantitative Analyses of Aggregation, Autofluorescence, and Reactivity Artifacts in a Screen for Inhibitors of a Thiol Protease. J. Med. Chem. 2010 ; 53: 37-51
-
(2010)
J. Med. Chem
, vol.53
, pp. 37-51
-
-
Jadhav, A.1
Ferreira, R.S.2
Klumpp, C.3
Mott, B.T.4
Austin, C.P.5
Inglese, J.6
Thomas, C.J.7
Maloney, D.J.8
Shoichet, B.K.9
Simeonov, A.10
-
23
-
-
0141719702
-
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
-
DOI 10.1038/nature01960
-
Howitz K. T., Bitterman K. J., Cohen H. Y., Lamming D. W., Lavu S., Wood J. G., Zipkin R. E., Chung P., Kisielewski A., Zhang L. L., Scherer B., Sinclair D. A.. Small Molecule Activators of Sirtuins Extend Saccharomyces cerevisiae Lifespan. Nature. 2003 ; 425: 191-196 (Pubitemid 37150899)
-
(2003)
Nature
, vol.425
, Issue.6954
, pp. 191-196
-
-
Howitz, K.T.1
Bitterman, K.J.2
Cohen, H.Y.3
Lamming, D.W.4
Lavu, S.5
Wood, J.G.6
Zipkin, R.E.7
Chung, P.8
Kisielewski, A.9
Zhang, L.-L.10
Scherer, B.11
Sinclair, D.A.12
-
24
-
-
77950246109
-
SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1
-
Pacholec M., Bleasdale J. E., Chrunyk B., Cunningham D., Flynn D., Garofalo R. S., Griffith D., Griffor M., Loulakis P., Pabst B., Qiu X., Stockman B., Thanabal V., Varghese A., Ward J., Withka J., Ahn K.. SRT1720, SRT2183, SRT1460, and Resveratrol Are Not Direct Activators of SIRT1. J. Biol. Chem. 2010 ; 285: 8340-8351
-
(2010)
J. Biol. Chem
, vol.285
, pp. 8340-8351
-
-
Pacholec, M.1
Bleasdale, J.E.2
Chrunyk, B.3
Cunningham, D.4
Flynn, D.5
Garofalo, R.S.6
Griffith, D.7
Griffor, M.8
Loulakis, P.9
Pabst, B.10
Qiu, X.11
Stockman, B.12
Thanabal, V.13
Varghese, A.14
Ward, J.15
Withka, J.16
Ahn, K.17
-
25
-
-
70350524083
-
Resveratrol Is Not a Direct Activator of SIRT1 Enzyme Activity
-
Beher D., Wu J., Cumine S., Kim K. W., Lu S. C., Atangan L., Wang M.. Resveratrol Is Not a Direct Activator of SIRT1 Enzyme Activity. Chem. Biol. Drug Des. 2009 ; 74: 619-624
-
(2009)
Chem. Biol. Drug des
, vol.74
, pp. 619-624
-
-
Beher, D.1
Wu, J.2
Cumine, S.3
Kim, K.W.4
Lu, S.C.5
Atangan, L.6
Wang, M.7
-
26
-
-
4344668661
-
Drug repositioning: Identifying and developing new uses for existing drugs
-
Ashburn T. T., Thor K. B.. Drug Repositioning: Identifying and Developing New Uses for Existing Drugs. Nat. Rev. Drug Discov. 2004 ; 3: 673-683 (Pubitemid 39173508)
-
(2004)
Nature Reviews Drug Discovery
, vol.3
, Issue.8
, pp. 673-683
-
-
Ashburn, T.T.1
Thor, K.B.2
-
27
-
-
78650012970
-
To Selectivity and beyond
-
Mack G. S.. To Selectivity and Beyond. Nat. Biotech. 2010 ; 28: 1259-1266
-
(2010)
Nat. Biotech
, vol.28
, pp. 1259-1266
-
-
MacK, G.S.1
-
28
-
-
0842325787
-
Histone Deacetylase Is a Target of Valproic Acid-Mediated Cellular Differentiation
-
DOI 10.1158/0008-5472.CAN-03-0799
-
Gurvich N., Tsygankova O. M., Meinkoth J. L., Klein P. S.. Histone Deacetylase Is a Target of Valproic Acid-Mediated Cellular Differentiation. Cancer Res. 2004 ; 64: 1079-1086 (Pubitemid 38176913)
-
(2004)
Cancer Research
, vol.64
, Issue.3
, pp. 1079-1086
-
-
Gurvich, N.1
Tsygankova, O.M.2
Meinkoth, J.L.3
Klein, P.S.4
-
29
-
-
72249094958
-
Discovery of Potent and Selective Histone Deacetylase Inhibitors via Focused Combinatorial Libraries of Cyclic αβ-tetrapeptides
-
Olsen C. A., Ghadiri M. R.. Discovery of Potent and Selective Histone Deacetylase Inhibitors via Focused Combinatorial Libraries of Cyclic αβ-tetrapeptides. J. Med. Chem. 2009 ; 52: 7836-7846
-
(2009)
J. Med. Chem
, vol.52
, pp. 7836-7846
-
-
Olsen, C.A.1
Ghadiri, M.R.2
-
30
-
-
37849019672
-
Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
-
DOI 10.1042/BJ20070779
-
Khan N., Jeffers M., Kumar S., Hackett C., Boldog F., Khramtsov N., Qian X., Mills E., Berghs S. C., Carey N., Finn P. W., Collins L. S., Tumber A., Ritchie J. W., Jensen P. B., Lichenstein H. S., Sehested M.. Determination of the Class and Isoform Selectivity of Small-Molecule Histone Deacetylase Inhibitors. Biochem. J. 2008 ; 409: 581-589 (Pubitemid 351184977)
-
(2008)
Biochemical Journal
, vol.409
, Issue.2
, pp. 581-589
-
-
Khan, N.1
Jeffers, M.2
Kumar, S.3
Hackett, C.4
Boldog, F.5
Khramtsov, N.6
Qian, X.7
Mills, E.8
Berghs, S.C.9
Carey, N.10
Finn, P.W.11
Collins, L.S.12
Tumber, A.13
Ritchie, J.W.14
Jensen, P.B.15
Lichenstein, H.S.16
Sehested, M.17
-
31
-
-
0034663486
-
Cloning and Characterization of a Novel Human Histone Deacetylase, HDAC8
-
Buggy J. J., Sideris M. L., Mak P., Lorimer D. D., McIntosh B., Clark J. M.. Cloning and Characterization of a Novel Human Histone Deacetylase, HDAC8. Biochem. J. 2000 ; 350: 199-205
-
(2000)
Biochem. J
, vol.350
, pp. 199-205
-
-
Buggy, J.J.1
Sideris, M.L.2
Mak, P.3
Lorimer, D.D.4
McIntosh, B.5
Clark, J.M.6
-
32
-
-
6344222799
-
Crystal structure of a eukaryotic zinc-dependent histone deacetylase, human HDAC8, complexed with a hydroxamic acid inhibitor
-
DOI 10.1073/pnas.0404603101
-
Vannini A., Volpari C., Filocamo G., Casavola E. C., Brunetti M., Renzoni D., Chakravarty P., Paolini C., De Francesco R., Gallinari P., Steinkühler C., Di Marco S.. Crystal Structure of a Eukaryotic Zinc-Dependent Histone Deacetylase, Human HDAC8, Complexed with a Hydroxamic Acid Inhibitor. Proc. Natl. Acad. Sci. U. S. A. 2004 ; 101: 15064-15069 (Pubitemid 39391719)
-
(2004)
Proceedings of the National Academy of Sciences of the United States of America
, vol.101
, Issue.42
, pp. 15064-15069
-
-
Vannini, A.1
Volpari, C.2
Filocamo, G.3
Casavola, E.C.4
Brunetti, M.5
Renzoni, D.6
Chakravarty, P.7
Paolini, C.8
De Francesco, R.9
Gallinari, P.10
Steinkuhler, C.11
Di Marco, S.12
-
33
-
-
0035965343
-
Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen
-
Phiel C. J., Zhang F., Huang E. Y., Guenther M. G., Lazar M. A., Klein P. S.. Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen. J. Biol. Chem. 2001 ; 276: 36734-36741
-
(2001)
J. Biol. Chem
, vol.276
, pp. 36734-36741
-
-
Phiel, C.J.1
Zhang, F.2
Huang, E.Y.3
Guenther, M.G.4
Lazar, M.A.5
Klein, P.S.6
-
34
-
-
35548936745
-
Structure-Activity Studies on Suramin Analogues as Inhibitors of NAD+-Dependent Histone Deacetylases (Sirtuins)
-
Trapp J., Meier R., Hongwiset D., Kassack M. U., Sippl W., Jung M.. Structure-Activity Studies on Suramin Analogues as Inhibitors of NAD+-Dependent Histone Deacetylases (Sirtuins). Chem. Med. Chem. 2007 ; 2: 1419-1431
-
(2007)
Chem. Med. Chem
, vol.2
, pp. 1419-1431
-
-
Trapp, J.1
Meier, R.2
Hongwiset, D.3
Kassack, M.U.4
Sippl, W.5
Jung, M.6
|